Managing Director

0000950123-21-002268.txt : 20210216 0000950123-21-002268.hdr.sgml : 20210216 20210216064521 ACCESSION NUMBER: 0000950123-21-002268 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM Oncology Impact Management LP CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 21632220 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001687078 XXXXXXXX 12-31-2020 12-31-2020 false MPM ONCOLOGY IMPACT MANAGEMENT, L.P.

450 KENDALL STREET CAMBRIDGE MA 02142

13F HOLDINGS REPORT 028-20107 N Ansbert Gadicke Managing Director (617) 425-9200 /s/Ansbert Gadicke Cambridge MA 02-12-2021 0 16 588509 false INFORMATION TABLE 2 3285.xml INFORMATION TABLE FOR FORM 13F ADC Therapeutics, Inc. Common H0036K147 17274 539648 SH SOLE 539648 0 0 Autolus Therapeutics Limited Common 05280R100 355 39740 SH SOLE 39740 0 0 AVROBIO, Inc. Common 05455M100 5078 364285 SH SOLE 364285 0 0 Black Diamond Therapeutcs, Inc. Common 09203E105 1398 43615 SH SOLE 43615 0 0 Epizyme, Inc. Common 29428V104 31002 2854737 SH SOLE 2854737 0 0 G1 Therapeutics, Inc. Common 3621LQ109 25614 1423794 SH SOLE 1423794 0 0 Harpoon Therapeutics, Inc. Common 41358P106 64753 3898422 SH SOLE 3898422 0 0 Intellia Therapeutics, Inc. Common 45826J105 6972 128162 SH SOLE 128162 0 0 iTeos Therapeutics, Inc. Common 46565G104 79665 2355557 SH SOLE 2355557 0 0 MEI Pharma, Inc. Common 552798202 26764 10137859 SH SOLE 10137859 0 0 Merus N.V. Common N5749R100 12286 700879 SH SOLE 700879 0 0 Oncorus, Inc. Common 68236R103 76849 2377031 SH SOLE 2377031 0 0 Repare Therapeutics, Inc. Common 760273102 81920 2388337 SH SOLE 2388337 0 0 TCR2 Therapeutics, Inc. Common 87808K106 104264 3370982 SH SOLE 3370982 0 0 Turning Point Therapeutics, Inc. Common 90041T108 37613 308686 SH SOLE 308686 0 0 YmAbs Therapeutics, Inc. Common 984241109 16699 337291 SH SOLE 337291 0 0